Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Oct 4, 2025
Transactions
165
Purchases
0
Sales
165
Purchase value
$0.00
Sale value
$120.56M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Sep 21, 2026Period of report Sep 17, 20260001470831-26-000897
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleSep 17, 2026
Common StockF1F2F3
8,721
$69.0136
$601.87K
496,965
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleSep 17, 2026
Common StockF1F4
Filing footnotes · 5
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.
F2Represents the weighted average sale price of the shares sold from $68.52 to $69.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $69.525 to $69.64 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5These shares are held by the NK 2026 GRAT, a grantor retained annuity trust of which the Reporting Person is the sole trustee and sole annuitant. The Reporting Person disclaims beneficial ownership of the shares held by the NK 2026 GRAT except to the extent of his pecuniary interest therein.
Filed Aug 20, 2026Period of report Aug 18, 20260001470831-26-000848
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Apuli MaricelChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Aug 3, 2026Period of report Jul 30, 20260001470831-26-000745
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Ellis AndreaDirector
4Rule 10b5-1 plan disclosed
Filed Jul 13, 2026Period of report Jul 9, 20260001470831-26-000709
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Cook Jennifer E.Director
4Rule 10b5-1 plan disclosed
Filed Jul 13, 2026Period of report Jul 9, 20260001470831-26-000708
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Cook Jennifer E.Director
4Rule 10b5-1 plan disclosed
Filed Jun 24, 2026Period of report Jun 22, 20260001470831-26-000636
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Valantine HannahDirector
4Rule 10b5-1 plan disclosed
Filed Jun 24, 2026Period of report Jun 22, 20260001470831-26-000635
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Cook Jennifer E.Director
4Rule 10b5-1 plan disclosed
Filed Jun 17, 2026Period of report Jun 15, 20260001470831-26-000550
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jun 8, 2026Period of report Jun 4, 20260001470831-26-000523
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed May 26, 2026Period of report May 21, 20260001470831-26-000488
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Trimarchi ThomasPresident and CFO
4Rule 10b5-1 plan disclosed
Filed May 19, 2026Period of report May 16, 20260001470831-26-000473
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Scott Randal W.Director
4Rule 10b5-1 plan disclosed
Filed May 19, 2026Period of report May 15, 20260001470831-26-000470
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed May 11, 2026Period of report May 7, 20260001470831-26-000423
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Apuli MaricelChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed May 4, 2026Period of report Apr 30, 20260001470831-26-000410
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 13, 2026Period of report Apr 9, 20260001470831-26-000361
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Mar 16, 2026Period of report Mar 12, 20260001470831-26-000275
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Valantine HannahDirector
4Rule 10b5-1 plan disclosed
Filed Mar 12, 2026Period of report Mar 10, 20260001470831-26-000260
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Ellis AndreaDirector
4Rule 10b5-1 plan disclosed
Filed Mar 6, 2026Period of report Mar 4, 20260001470831-26-000252
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Valantine HannahDirector
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Feb 27, 20260001470831-26-000236
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Apuli MaricelChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Feb 27, 2026Period of report Feb 26, 20260001470831-26-000225
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 23, 2026Period of report Feb 19, 20260001470831-26-000214
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Apuli MaricelChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 16, 20260001470831-26-000186
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Trimarchi ThomasPresident and CFO
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 16, 20260001470831-26-000184
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Scott Randal W.Director
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 17, 20260001470831-26-000182
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 12, 2026Period of report Feb 10, 20260001470831-26-000118
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jan 12, 2026Period of report Jan 8, 20260001470831-26-000026
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 12, 20250001470831-25-000422
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Apuli MaricelChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Dec 10, 2025Period of report Dec 8, 20250001470831-25-000392
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Dec 8, 2025Period of report Dec 4, 20250001470831-25-000386
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Nov 24, 2025Period of report Nov 20, 20250001470831-25-000366
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Lo AndrewDirector
4
Filed Nov 19, 2025Period of report Nov 17, 20250001470831-25-000357
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 18, 2025
Common StockF3
24,007
$65.2315
$1.57M
81,576
Indirect
Scott Randal W.Director
4Rule 10b5-1 plan disclosed
Filed Nov 19, 2025Period of report Nov 17, 20250001470831-25-000355
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Trimarchi ThomasPresident and CFO
4Rule 10b5-1 plan disclosed
Filed Nov 18, 2025Period of report Nov 16, 20250001470831-25-000351
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Valantine HannahDirector
4
Filed Nov 14, 2025Period of report Nov 12, 20250001470831-25-000317
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 12, 2025
Common Stock
25,484
$66.07
$1.68M
7,465
Direct
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Nov 10, 2025Period of report Nov 6, 20250001470831-25-000302
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Daniels Ronald JDirector
4
Filed Nov 7, 2025Period of report Nov 6, 20250001470831-25-000297
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 6, 2025
Common StockF1
61,031
$63.7217
$3.89M
16,991
Direct
McCormick FrankDirector
4Rule 10b5-1 plan disclosed
Filed Oct 31, 2025Period of report Oct 29, 20250001470831-25-000282
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
McCormick FrankDirector
4Rule 10b5-1 plan disclosed
Filed Oct 29, 2025Period of report Oct 27, 20250001470831-25-000278
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Kumar NeilDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Oct 10, 2025Period of report Oct 8, 20250001470831-25-000256
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
F3
1,279
$69.5696
$88.98K
495,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Aug 19, 2026
Common StockF1F6F7
8,100
$83.8588
$679.26K
507,586
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleAug 19, 2026
Common StockF1F8F7
1,800
$84.6867
$152.44K
505,786
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleAug 19, 2026
Common StockF1F7
100
$85.65
$8.57K
505,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleAug 18, 2026
Common StockF1F2
1,900
$81.1494
$154.18K
276,407
Direct
SaleAug 18, 2026
Common StockF1F3
17,279
$82.2104
$1.42M
259,128
Direct
SaleAug 18, 2026
Common StockF1F4
14,602
$82.9922
$1.21M
244,526
Direct
SaleAug 18, 2026
Common StockF1F5
1,199
$83.7732
$100.44K
243,327
Direct
Filing footnotes · 9
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.
F2Represents the weighted average sale price of the shares sold from $80.54 to $81.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $81.62 to $82.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $82.62 to $83.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $83.65 to $83.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $83.34 to $84.31 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F8Represents the weighted average sale price of the shares sold from $84.35 to $85.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9These shares are held by the NK 2026 GRAT, a grantor retained annuity trust of which the Reporting Person is the sole trustee and sole annuitant. The Reporting Person disclaims beneficial ownership of the shares held by the NK 2026 GRAT except to the extent of his pecuniary interest therein.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.
F21/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.
F21/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.
F3The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.
F41/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
F1Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.
F2Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.
F4The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.
F51/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.
F61/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
F1Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.
F2Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.
F4The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.
F5One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.
F2Represents the weighted average sale price of the shares sold from $66.10 to $67.095 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $67.10 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F41/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.
F51/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 5, 2026
Common StockF1F8F3
8,437
$67.8848
$572.74K
520,102
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 5, 2026
Common StockF1F9F3
4,416
$68.9593
$304.52K
515,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 5, 2026
Common StockF1F7F3
7,148
$67.199
$480.34K
4,331,299
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 5, 2026
Common StockF1F8F3
8,437
$67.8848
$572.74K
4,322,862
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 5, 2026
Common StockF1F9F3
4,415
$68.9593
$304.46K
4,318,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F2F3
2,200
$65.7202
$144.58K
553,486
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F4F3
1,429
$66.723
$95.35K
552,057
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F5F3
15,921
$67.7378
$1.08M
536,136
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F6F3
450
$68.2697
$30.72K
535,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F2F3
2,200
$65.7202
$144.58K
4,356,247
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F4F3
1,429
$66.723
$95.35K
4,354,818
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F5F3
15,921
$67.7377
$1.08M
4,338,897
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJun 4, 2026
Common StockF1F6F3
450
$68.2697
$30.72K
4,338,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 9
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F2Represents the weighted average sale price of the shares sold from $65.145 to $66.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $66.15 to $67.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $67.17 to $68.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $68.17 to $68.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $66.59 to $67.58 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $67.61 to $68.605 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $68.61 to $69.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F2Represents the weighted average sale price of the shares sold from $66.81 to $67.80 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $67.81 to $68.80 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $68.81 to $69.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $69.86 to $70.85 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $70.86 to $70.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F1Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 41,193 shares of Common Stock underlying the Reporting Person's RSUs.
F2This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F3Represents the weighted average sale price of the shares sold from $64.34 to $65.33 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $65.54 to $66.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.
F2Represents the weighted average sale price of the shares sold from $66.08 to $67.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $67.10 to $68.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $68.10 to $68.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5One-third of the shares underlying the option will vest on June 21, 2024; thereafter, one-third of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 8, 2026
Common StockF1F7F3
5,077
$67.3455
$341.91K
556,636
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 8, 2026
Common StockF1F8F3
950
$68.3477
$64.93K
555,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 8, 2026
Common StockF1F6F3
13,974
$66.6505
$931.37K
4,364,473
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 8, 2026
Common StockF1F7F3
5,076
$67.3455
$341.85K
4,359,397
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 8, 2026
Common StockF1F8F3
950
$68.3477
$64.93K
4,358,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 7, 2026
Common StockF1F2F3
11,217
$67.495
$757.09K
584,469
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 7, 2026
Common StockF1F4F3
8,333
$68.3775
$569.79K
576,136
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 7, 2026
Common StockF1F5F3
450
$69.0911
$31.09K
575,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 7, 2026
Common StockF1F2F3
11,217
$67.4949
$757.09K
4,387,230
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 7, 2026
Common StockF1F4F3
8,334
$68.3775
$569.86K
4,378,896
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMay 7, 2026
Common StockF1F5F3
449
$69.0911
$31.02K
4,378,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 8
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F2Represents the weighted average sale price of the shares sold from $67.02 to $68.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $68.02 to $69.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $69.02 to $69.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $66.10 to $67.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $67.10 to $68.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $68.17 to $68.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 10, 2026
Common StockF1F10F3
20,000
$74.6038
$1.49M
4,398,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 9, 2026
Common StockF1F2F3
7,200
$73.6444
$530.24K
628,486
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 9, 2026
Common StockF1F4F3
5,300
$74.6044
$395.40K
623,186
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 9, 2026
Common StockF1F5F3
7,500
$75.5548
$566.66K
615,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 9, 2026
Common StockF1F6F3
7,072
$73.6427
$520.80K
4,431,375
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 9, 2026
Common StockF1F7F3
5,128
$74.5669
$382.38K
4,426,247
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleApr 9, 2026
Common StockF1F8F3
7,800
$75.5287
$589.12K
4,418,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 10
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F10Represents the weighted average sale price of the shares sold from $74.27 to $75.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $73.19 to $74.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $74.19 to $75.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $75.22 to $76.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $73.15 to $74.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $74.18 to $75.145 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $75.18 to $76.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $74.26 to $75.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 13, 2026
Common StockF1F9F3
10,310
$69.1997
$713.45K
635,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 13, 2026
Common StockF1F10F3
10,241
$68.3864
$700.35K
4,448,206
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 13, 2026
Common StockF1F11F3
9,759
$69.2251
$675.57K
4,438,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 12, 2026
Common StockF1F2F3
14,337
$68.4808
$981.81K
661,349
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 12, 2026
Common StockF1F4F3
5,363
$69.3176
$371.75K
655,986
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 12, 2026
Common StockF1F5F3
300
$70.15
$21.05K
655,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 12, 2026
Common StockF1F6F3
13,885
$68.4686
$950.69K
4,464,562
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 12, 2026
Common StockF1F7F3
5,815
$69.2913
$402.93K
4,458,747
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleMar 12, 2026
Common StockF1F5F3
300
$70.15
$21.05K
4,458,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 11
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F10Represents the weighted average sale price of the shares sold from $67.82 to $68.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F11Represents the weighted average sale price of the shares sold from $68.82 to $69.55 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $67.935 to $68.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $68.94 to $69.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $70.1 to $70.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $67.935 to $68.92 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $68.94 to $69.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $67.76 to $68.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $68.76 to $69.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.
F2One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.
F2Represents the weighted average sale price of the shares sold from $64.255 to $65.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.
F2Represents the weighted average sale price of the shares sold from $66.42 to $67.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $67.42 to $68.31 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4The stock option vests and becomes exercisable in three annual installments after October 25, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F2Represents the weighted average sale price of the shares sold from $70.61 to $71.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $71.61 to $72.57 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $72.61 to $72.86 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F1Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 8,377 shares of Common Stock underlying the Reporting Person's RSUs.
F2Includes 510 shares of the Issuer's Common Stock acquired by the Reporting Person on February 13, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
F3This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.
F1Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 37,503 shares of Common Stock underlying the Reporting Person's RSUs.
F2This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F3Represents the weighted average sale price of the shares sold from $74.30 to $75.19 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.
F2Represents the weighted average sale price of the shares sold from $73.74 to $74.67 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $74.82 to $75.815 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $75.82 to $76.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F51/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F8F3
3,716
$71.4416
$265.48K
684,164
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F9F3
4,484
$72.635
$325.70K
679,680
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F10F3
3,994
$73.2535
$292.57K
675,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F7F3
7,860
$70.7005
$555.71K
4,490,587
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F11F3
3,775
$71.4581
$269.75K
4,486,812
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F12F3
4,404
$72.6472
$319.94K
4,482,408
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 11, 2026
Common StockF1F13F3
3,961
$73.2505
$290.15K
4,478,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 10, 2026
Common StockF1F2F3
14,201
$71.8018
$1.02M
701,485
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 10, 2026
Common StockF1F4F3
5,799
$72.2823
$419.17K
695,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 10, 2026
Common StockF1F5F3
14,040
$71.7953
$1.01M
4,504,407
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleFeb 10, 2026
Common StockF1F6F3
5,960
$72.2737
$430.75K
4,498,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 13
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F10Represents the weighted average sale price of the shares sold from $73.09 to $73.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F11Represents the weighted average sale price of the shares sold from $71.1 to $72.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F12Represents the weighted average sale price of the shares sold from $72.1 to $73.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F13Represents the weighted average sale price of the shares sold from $73.1 to $73.4 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $71.08 to $72.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $72.08 to $72.55 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $71.02 to $72.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $72.02 to $72.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $70.09 to $71.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $71.09 to $72.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $72.09 to $73.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F9F3
6,955
$76.7173
$533.57K
726,580
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F10F3
10,519
$77.6086
$816.36K
716,061
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F11F3
375
$78.192
$29.32K
715,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F12F3
1,401
$75.6088
$105.93K
4,537,046
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F13F3
6,067
$76.527
$464.29K
4,530,979
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F14F3
10,677
$77.4577
$827.02K
4,520,302
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 9, 2026
Common StockF1F15F3
1,855
$78.1035
$144.88K
4,518,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 8, 2026
Common StockF1F2F3
11,515
$73.6446
$848.02K
744,171
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 8, 2026
Common StockF1F4F3
8,085
$74.3773
$601.34K
736,086
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 8, 2026
Common StockF1F5F3
400
$75.1602
$30.06K
735,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 8, 2026
Common StockF1F6F3
11,565
$73.6542
$851.81K
4,546,882
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 8, 2026
Common StockF1F7F3
8,135
$74.3775
$605.06K
4,538,747
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleJan 8, 2026
Common StockF1F5F3
300
$75.2033
$22.56K
4,538,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 15
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F10Represents the weighted average sale price of the shares sold from $77.16 to $78.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F11Represents the weighted average sale price of the shares sold from $78.16 to $78.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F12Represents the weighted average sale price of the shares sold from $74.99 to $75.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F13Represents the weighted average sale price of the shares sold from $75.99 to $76.985 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F14Represents the weighted average sale price of the shares sold from $76.99 to $77.96 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F15Represents the weighted average sale price of the shares sold from $78.00 to $78.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $73.05 to $74.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $74.06 to $74.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $75.09 to $75.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $73.08 to $74.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $74.08 to $75.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $75.12 to $76.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $76.13 to $77.125 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 60,975 shares of Common Stock underlying the Reporting Person's RSUs.
F3This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F4Represents the weighted average sale price of the shares sold from $74.12 to $75.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $75.13 to $75.49 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F7The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 5, 2025
Common StockF1F7F3
7,483
$73.7607
$551.95K
755,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 5, 2025
Common StockF1F9F3
12,288
$73.0411
$897.53K
4,566,159
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 5, 2025
Common StockF1F10F3
7,712
$73.7498
$568.76K
4,558,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 4, 2025
Common StockF1F2F3
2,100
$73.1611
$153.64K
793,586
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 4, 2025
Common StockF1F4F3
12,192
$74.4243
$907.38K
781,394
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 4, 2025
Common StockF1F5F3
5,708
$74.7966
$426.94K
775,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 4, 2025
Common StockF1F8F3
2,100
$73.1554
$153.63K
4,596,347
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 4, 2025
Common StockF1F4F3
12,200
$74.4238
$907.97K
4,584,147
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleDec 4, 2025
Common StockF1F5F3
5,700
$74.7996
$426.36K
4,578,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 10
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F10Represents the weighted average sale price of the shares sold from $73.42 to $74.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $72.71 to $73.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $73.73 to $74.72 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $74.73 to $74.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $72.46 to $73.45 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $73.46 to $74.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $72.71 to $73.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $72.41 to $73.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F2Represents the weighted average sale price of the shares sold from $64.49 to $65.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $65.49 to $66.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $66.49 to $67.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F1Represents the weighted average sale price of the shares sold from $65.975 to $66.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $66.975 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $64.58 to $65.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $65.58 to $66.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.
F2Represents the weighted average sale price of the shares sold from $65.64 to $66.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $66.65 to $67.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4One-third of the shares underlying the option vested on June 21, 2024; thereafter, one-third of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the Reporting Person's continued service on the board of directors of the Issuer.
F1Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,547 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.
F2This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F3Represents the weighted average sale price of the shares sold from $65.575 to $66.57 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $66.61 to $67.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 7, 2025
Common StockF1F6F3
7,308
$61.8714
$452.16K
4,598,647
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 7, 2025
Common StockF1F7F3
200
$62.805
$12.56K
4,598,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 7, 2025
Common StockF1F8F3
12,234
$61.1298
$747.86K
803,452
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 7, 2025
Common StockF1F9F3
7,546
$61.8657
$466.84K
795,906
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 7, 2025
Common StockF1F10F3
220
$62.7936
$13.81K
795,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 6, 2025
Common StockF1F2F3
12,576
$62.9108
$791.17K
4,625,871
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 6, 2025
Common StockF1F4F3
7,324
$63.5467
$465.42K
4,618,547
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 6, 2025
Common StockF1F3
100
$64.39
$6.44K
4,618,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 6, 2025
Common StockF1F2F3
12,529
$62.9088
$788.18K
823,157
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 6, 2025
Common StockF1F4F3
7,371
$63.5561
$468.47K
815,786
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleNov 6, 2025
Common StockF1F3
100
$64.39
$6.44K
815,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 10
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F10Represents the weighted average sale price of the shares sold from $62.68 to $62.83 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2Represents the weighted average sale price of the shares sold from $62.245 to $63.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $63.25 to $64.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $60.59 to $61.58 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $61.59 to $62.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F7Represents the weighted average sale price of the shares sold from $62.78 to $62.83 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F8Represents the weighted average sale price of the shares sold from $60.57 to $61.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F9Represents the weighted average sale price of the shares sold from $61.58 to $62.37 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F1Represents the weighted average sale price of the shares sold from $63.70 to $63.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2The shares subject to this option vested and became exercisable in three annual installments from February 12, 2020 to February 12, 2023.
IndirectBy the Francis P. McCormick Rev Trust U/A DTD 1/27/2017
SaleOct 29, 2025
Common StockF1F3
31,116
$66.1958
$2.06M
735,467
IndirectBy the Francis P. McCormick Rev Trust U/A DTD 1/27/2017
SaleOct 29, 2025
Common StockF1F4
3,497
$67.5235
$236.13K
731,970
IndirectBy the Francis P. McCormick Rev Trust U/A DTD 1/27/2017
SaleOct 29, 2025
Common StockF1F5
8,598
$68.5026
$588.99K
723,372
IndirectBy the Francis P. McCormick Rev Trust U/A DTD 1/27/2017
SaleOct 29, 2025
Common StockF1F6
43,393
$69.2358
$3.00M
679,979
IndirectBy the Francis P. McCormick Rev Trust U/A DTD 1/27/2017
Filing footnotes · 6
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.
F2Represents the weighted average sale price of the shares sold from $65.00 to $65.999 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3Represents the weighted average sale price of the shares sold from $66.00 to $66.9875 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4Represents the weighted average sale price of the shares sold from $67.00 to $67.996 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $68.005 to $68.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F6Represents the weighted average sale price of the shares sold from $69.00 to $69.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleOct 9, 2025
Common StockF1F5F3
20,000
$54.8023
$1.10M
835,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleOct 8, 2025
Common StockF1F2F3
8,706
$54.3882
$473.50K
4,669,741
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleOct 8, 2025
Common StockF1F4F3
11,294
$55.0886
$622.17K
4,658,447
IndirectBy Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
SaleOct 8, 2025
Common StockF1F2F3
8,705
$54.3883
$473.45K
866,981
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
SaleOct 8, 2025
Common StockF1F4F3
11,295
$55.0886
$622.23K
855,686
IndirectBy Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Filing footnotes · 5
F1This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
F2Represents the weighted average sale price of the shares sold from $53.82 to $54.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4Represents the weighted average sale price of the shares sold from $54.82 to $55.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F5Represents the weighted average sale price of the shares sold from $54.49 to $55.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.